Angiotensin II receptor blockers help relax your veins and arteries to lower your blood pressure and make it easier for your heart to pump blood.
The latest research study released by Market IntelliX evaluates market size and forecasts of Angiotensin II Receptor Blockers in global, including the following market information:
Global Angiotensin II Receptor Blockers Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Angiotensin II Receptor Blockers Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Angiotensin II Receptor Blockers companies in 2021 (%)
The global Angiotensin II Receptor Blockers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Azilsartan Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Angiotensin II Receptor Blockers include Merck & Co., AstraZeneca, Novartis, Teva, Bayer, GlaxoSmithKline, Sun Pharmaceutical and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Angiotensin II Receptor Blockers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Angiotensin II Receptor Blockers Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Angiotensin II Receptor Blockers Market Segment Percentages, by Type, 2021 (%)
Azilsartan
Candesartan
Eprosartan
Irbesartan
Losartan
Olmesartan
Telmisartan
Valsartan
Global Angiotensin II Receptor Blockers Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Angiotensin II Receptor Blockers Market Segment Percentages, by Application, 2021 (%)
Chronic Kidney Diseases
Heart Failure
Kidney Failure in Diabetes
Global Angiotensin II Receptor Blockers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Angiotensin II Receptor Blockers Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Angiotensin II Receptor Blockers revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Angiotensin II Receptor Blockers revenues share in global market, 2021 (%)
Key companies Angiotensin II Receptor Blockers sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Angiotensin II Receptor Blockers sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Merck & Co.
AstraZeneca
Novartis
Teva
Bayer
GlaxoSmithKline
Sun Pharmaceutical
Mylan
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Angiotensin II Receptor Blockers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Angiotensin II Receptor Blockers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Angiotensin II Receptor Blockers Overall Market Size
2.1 Global Angiotensin II Receptor Blockers Market Size: 2021 VS 2028
2.2 Global Angiotensin II Receptor Blockers Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Angiotensin II Receptor Blockers Sales: 2017-2028
3 Company Landscape
3.1 Top Angiotensin II Receptor Blockers Players in Global Market
3.2 Top Global Angiotensin II Receptor Blockers Companies Ranked by Revenue
3.3 Global Angiotensin II Receptor Blockers Revenue by Companies
3.4 Global Angiotensin II Receptor Blockers Sales by Companies
3.5 Global Angiotensin II Receptor Blockers Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Angiotensin II Receptor Blockers Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Angiotensin II Receptor Blockers Product Type
3.8 Tier 1, Tier 2 and Tier 3 Angiotensin II Receptor Blockers Players in Global Market
3.8.1 List of Global Tier 1 Angiotensin II Receptor Blockers Companies
3.8.2 List of Global Tier 2 and Tier 3 Angiotensin II Receptor Blockers Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Angiotensin II Receptor Blockers Market Size Markets, 2021 & 2028
4.1.2 Azilsartan
4.1.3 Candesartan
4.1.4 Eprosartan
4.1.5 Irbesartan
4.1.6 Losartan
4.1.7 Olmesartan
4.1.8 Telmisartan
4.1.9 Valsartan
4.2 By Type - Global Angiotensin II Receptor Blockers Revenue & Forecasts
4.2.1 By Type - Global Angiotensin II Receptor Blockers Revenue, 2017-2022
4.2.2 By Type - Global Angiotensin II Receptor Blockers Revenue, 2023-2028
4.2.3 By Type - Global Angiotensin II Receptor Blockers Revenue Market Share, 2017-2028
4.3 By Type - Global Angiotensin II Receptor Blockers Sales & Forecasts
4.3.1 By Type - Global Angiotensin II Receptor Blockers Sales, 2017-2022
4.3.2 By Type - Global Angiotensin II Receptor Blockers Sales, 2023-2028
4.3.3 By Type - Global Angiotensin II Receptor Blockers Sales Market Share, 2017-2028
4.4 By Type - Global Angiotensin II Receptor Blockers Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Angiotensin II Receptor Blockers Market Size, 2021 & 2028
5.1.2 Chronic Kidney Diseases
5.1.3 Heart Failure
5.1.4 Kidney Failure in Diabetes
5.2 By Application - Global Angiotensin II Receptor Blockers Revenue & Forecasts
5.2.1 By Application - Global Angiotensin II Receptor Blockers Revenue, 2017-2022
5.2.2 By Application - Global Angiotensin II Receptor Blockers Revenue, 2023-2028
5.2.3 By Application - Global Angiotensin II Receptor Blockers Revenue Market Share, 2017-2028
5.3 By Application - Global Angiotensin II Receptor Blockers Sales & Forecasts
5.3.1 By Application - Global Angiotensin II Receptor Blockers Sales, 2017-2022
5.3.2 By Application - Global Angiotensin II Receptor Blockers Sales, 2023-2028
5.3.3 By Application - Global Angiotensin II Receptor Blockers Sales Market Share, 2017-2028
5.4 By Application - Global Angiotensin II Receptor Blockers Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Angiotensin II Receptor Blockers Market Size, 2021 & 2028
6.2 By Region - Global Angiotensin II Receptor Blockers Revenue & Forecasts
6.2.1 By Region - Global Angiotensin II Receptor Blockers Revenue, 2017-2022
6.2.2 By Region - Global Angiotensin II Receptor Blockers Revenue, 2023-2028
6.2.3 By Region - Global Angiotensin II Receptor Blockers Revenue Market Share, 2017-2028
6.3 By Region - Global Angiotensin II Receptor Blockers Sales & Forecasts
6.3.1 By Region - Global Angiotensin II Receptor Blockers Sales, 2017-2022
6.3.2 By Region - Global Angiotensin II Receptor Blockers Sales, 2023-2028
6.3.3 By Region - Global Angiotensin II Receptor Blockers Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Angiotensin II Receptor Blockers Revenue, 2017-2028
6.4.2 By Country - North America Angiotensin II Receptor Blockers Sales, 2017-2028
6.4.3 US Angiotensin II Receptor Blockers Market Size, 2017-2028
6.4.4 Canada Angiotensin II Receptor Blockers Market Size, 2017-2028
6.4.5 Mexico Angiotensin II Receptor Blockers Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Angiotensin II Receptor Blockers Revenue, 2017-2028
6.5.2 By Country - Europe Angiotensin II Receptor Blockers Sales, 2017-2028
6.5.3 Germany Angiotensin II Receptor Blockers Market Size, 2017-2028
6.5.4 France Angiotensin II Receptor Blockers Market Size, 2017-2028
6.5.5 U.K. Angiotensin II Receptor Blockers Market Size, 2017-2028
6.5.6 Italy Angiotensin II Receptor Blockers Market Size, 2017-2028
6.5.7 Russia Angiotensin II Receptor Blockers Market Size, 2017-2028
6.5.8 Nordic Countries Angiotensin II Receptor Blockers Market Size, 2017-2028
6.5.9 Benelux Angiotensin II Receptor Blockers Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Angiotensin II Receptor Blockers Revenue, 2017-2028
6.6.2 By Region - Asia Angiotensin II Receptor Blockers Sales, 2017-2028
6.6.3 China Angiotensin II Receptor Blockers Market Size, 2017-2028
6.6.4 Japan Angiotensin II Receptor Blockers Market Size, 2017-2028
6.6.5 South Korea Angiotensin II Receptor Blockers Market Size, 2017-2028
6.6.6 Southeast Asia Angiotensin II Receptor Blockers Market Size, 2017-2028
6.6.7 India Angiotensin II Receptor Blockers Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Angiotensin II Receptor Blockers Revenue, 2017-2028
6.7.2 By Country - South America Angiotensin II Receptor Blockers Sales, 2017-2028
6.7.3 Brazil Angiotensin II Receptor Blockers Market Size, 2017-2028
6.7.4 Argentina Angiotensin II Receptor Blockers Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Angiotensin II Receptor Blockers Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Angiotensin II Receptor Blockers Sales, 2017-2028
6.8.3 Turkey Angiotensin II Receptor Blockers Market Size, 2017-2028
6.8.4 Israel Angiotensin II Receptor Blockers Market Size, 2017-2028
6.8.5 Saudi Arabia Angiotensin II Receptor Blockers Market Size, 2017-2028
6.8.6 UAE Angiotensin II Receptor Blockers Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Merck & Co.
7.1.1 Merck & Co. Corporate Summary
7.1.2 Merck & Co. Business Overview
7.1.3 Merck & Co. Angiotensin II Receptor Blockers Major Product Offerings
7.1.4 Merck & Co. Angiotensin II Receptor Blockers Sales and Revenue in Global (2017-2022)
7.1.5 Merck & Co. Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Angiotensin II Receptor Blockers Major Product Offerings
7.2.4 AstraZeneca Angiotensin II Receptor Blockers Sales and Revenue in Global (2017-2022)
7.2.5 AstraZeneca Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Angiotensin II Receptor Blockers Major Product Offerings
7.3.4 Novartis Angiotensin II Receptor Blockers Sales and Revenue in Global (2017-2022)
7.3.5 Novartis Key News
7.4 Teva
7.4.1 Teva Corporate Summary
7.4.2 Teva Business Overview
7.4.3 Teva Angiotensin II Receptor Blockers Major Product Offerings
7.4.4 Teva Angiotensin II Receptor Blockers Sales and Revenue in Global (2017-2022)
7.4.5 Teva Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Angiotensin II Receptor Blockers Major Product Offerings
7.5.4 Bayer Angiotensin II Receptor Blockers Sales and Revenue in Global (2017-2022)
7.5.5 Bayer Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Angiotensin II Receptor Blockers Major Product Offerings
7.6.4 GlaxoSmithKline Angiotensin II Receptor Blockers Sales and Revenue in Global (2017-2022)
7.6.5 GlaxoSmithKline Key News
7.7 Sun Pharmaceutical
7.7.1 Sun Pharmaceutical Corporate Summary
7.7.2 Sun Pharmaceutical Business Overview
7.7.3 Sun Pharmaceutical Angiotensin II Receptor Blockers Major Product Offerings
7.7.4 Sun Pharmaceutical Angiotensin II Receptor Blockers Sales and Revenue in Global (2017-2022)
7.7.5 Sun Pharmaceutical Key News
7.8 Mylan
7.8.1 Mylan Corporate Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Angiotensin II Receptor Blockers Major Product Offerings
7.8.4 Mylan Angiotensin II Receptor Blockers Sales and Revenue in Global (2017-2022)
7.8.5 Mylan Key News
8 Global Angiotensin II Receptor Blockers Production Capacity, Analysis
8.1 Global Angiotensin II Receptor Blockers Production Capacity, 2017-2028
8.2 Angiotensin II Receptor Blockers Production Capacity of Key Manufacturers in Global Market
8.3 Global Angiotensin II Receptor Blockers Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Angiotensin II Receptor Blockers Supply Chain Analysis
10.1 Angiotensin II Receptor Blockers Industry Value Chain
10.2 Angiotensin II Receptor Blockers Upstream Market
10.3 Angiotensin II Receptor Blockers Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Angiotensin II Receptor Blockers Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|